Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)

NCT06859684 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma (Icc)
HAIC
Durvalumab

Interventions

DRUG: Durvalumab
DRUG: hepatic arterial infusion chemotherapy (HAIC)
DRUG: Lenvatinib

Sponsor

West China Hospital